New Drug Discovery Platform Based on
Deep Phosphoproteomic Profiling

Lighting the Path to Precision Medicine.

About Kinase Insight

Kinase Insight pioneers a state-of-the-art drug discovery service platform, utilizing advanced equipment including Orbitrap Exploris 480 and Q Exactive Plus. Our mission is to deliver top-notch proteomic analysis services to a diverse range of pharmaceutical enterprises. With a specialized deep phosphoproteomic technology platform, coupled with proprietary methods and a robust bioinformatics platform, we offer comprehensive analyses covering total protein, total phosphorylation, and tyrosine phosphorylation. Our services provide efficient solutions for drug development and patient treatment, ensuring high-quality results and contributing to advancements in the field.

 

 

 

 

 

 

Targeted Protein Degradation (TPD) Omics Analysis Service

Targeted analysis of TPD drugs based on DIA label-free quantitative proteomics.

More

Tyrosine Phosphorylation Proteomics Analysis Service

Hypothesis-free and direct analysis of TKI targeting capabilities within cells.

More

Efficient and Comprehensive Solutions Based on Specialized Phosphoproteomics Platform

Covers three data dimensions: total protein, total phosphorylation, and tyrosine phosphorylation.

Neoantigen Sequencing Service

High-Throughput Antibody Screening Service

Oligo Mass Spectrometry Characterization

Macromolecule Drugs (mAb,ADC,AAV) Mass Spectrometry Characterization Service